Trial · NCT01555671
Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women
NCT01555671, Phase 4, Completed, Kanuni Sultan Suleyman Training and Research Hospital; results first posted 2021-09-30
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women. Trials, record NCT01555671. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01555671
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women
- NCT number
- NCT01555671
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 250 participants, actual
- Lead sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
- Conditions
- Labor Pain
- Interventions
- Meperidine, Saline
- First posted
- 2012-03-15
- Last updated
- 2021-09-30
- Results first posted
- 2021-09-30
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Duration of Active Phase of Labour | 24h | The primary outcome is to evaluate whether meperidine is effective in shortening the duration of the active phase of labor |
| Secondary | Total Duration of Labour | 24h | Total time of delivery of patients who gave birth including the second stage of delivery |
| Secondary | Duration of the Second Stage of Labour | 24h | The period of time until the birth of the baby, since the patient being followed for delivery |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Duration of Active Phase of Labour | 24h | women giving birth at term period | minutes | MEAN |
| SECONDARY | Total Duration of Labour | 24h | Total time of delivery of patients who gave birth including the second stage of delivery | minutes | MEAN |
| SECONDARY | Duration of the Second Stage of Labour | 24h | duration of the second stage of labour | minutes | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Duration of Active Phase of Labour | Meperidine Administration Group | 249 | Standard Deviation 122 | minutes | |
| The Duration of Active Phase of Labour | Plasebo Group | 304 | Standard Deviation 167 | minutes | |
| Total Duration of Labour | Meperidine Administration Group | 273 | Standard Deviation 129 | minutes | |
| Total Duration of Labour | Plasebo Group | 331 | Standard Deviation 177 | minutes | |
| Duration of the Second Stage of Labour | Meperidine Administration Group | 24 | Standard Deviation 15 | minutes | |
| Duration of the Second Stage of Labour | Plasebo Group | 27 | Standard Deviation 22 | minutes |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Study Group | 125 | |
| Overall Study | STARTED | Control Group | 125 | |
| Overall Study | COMPLETED | Study Group | 105 | |
| Overall Study | COMPLETED | Control Group | 100 | |
| Overall Study | NOT COMPLETED | Study Group | 20 | |
| Overall Study | NOT COMPLETED | Control Group | 25 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | emezis | Gastrointestinal disorders | Study Group | 20 | 105 | 24 |
| other | emezis | Gastrointestinal disorders | Control Group | 4 | 100 | 4 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Study Group | ||
| Total, all-cause mortality | Control Group | ||
| Total, other adverse events | Study Group | 20 | 105 |
| Total, other adverse events | Control Group | 4 | 100 |
| Total, serious adverse events | Study Group | 0 | 105 |
| Total, serious adverse events | Control Group | 0 | 100 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Study Group vs Control Group: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01555671
GET https://conductscience.org/api/trials/v1/NCT01555671/registered